
Photo: Unsplash
"Is ashwagandha banned in Europe?" is one of the most common questions we get from European buyers, and headlines haven't helped. The honest answer is: not across the EU, but yes in some places, with restrictions in others and an EU-level review that has been discussed but not started. If you sell ashwagandha supplements in Europe, here's where things stand as of October 2026, and how to plan around it.
In short: Denmark has banned ashwagandha in food supplements. Poland allows only root powder within set limits and not for children or pregnant or breastfeeding women. France has moved to restrict it, and the Netherlands has announced it intends to ban it. In 2024, national food safety authorities recommended an EU-level review under Article 8 of Regulation (EC) No 1925/2006, but that procedure hadn't been formally started. Elsewhere in the EU, ashwagandha food supplements remain on sale under national rules. The UK and the USA haven't banned it.
Why ashwagandha is being questioned
Ashwagandha, Withania somnifera, has a long history in Ayurveda and became one of the best-selling botanical supplements in Europe over the last decade. Regulators' concerns centre on safety rather than effectiveness: reports of liver problems in some users, possible effects on thyroid and hormones, and uncertainty about use in pregnancy. Denmark's food authority based its ban on a 2020 risk assessment by the Technical University of Denmark, which concluded that it couldn't establish a safe intake level for the root or extracts.
Industry groups dispute that conclusion and point to clinical studies that report good tolerability. Our aim here isn't to settle the science. It's to show what the rules currently say, because that's what decides whether a product can be sold.
Country by country
| Country | Status (October 2026) | What it means for brands |
|---|---|---|
| Denmark | Banned in food supplements | Ashwagandha supplements can't be sold |
| Poland | Restricted: root powder only, with limits on dose and withanolides; not for children or pregnant or breastfeeding women | Products must fit the national limits and warnings |
| France | Restrictive national measures; reports differ on the exact scope | Check current French rules carefully before launch |
| Netherlands | Government has announced its intention to ban | Plan for a possible withdrawal; follow the final decision |
| Other EU countries | Generally permitted under national food supplement rules, sometimes with warnings or limits | Check each target market's list and notification rules |
| EU level | Article 8 review recommended in 2024, not formally started | An EU-wide decision is possible later; nothing EU-wide yet |
| United Kingdom | Permitted | Normal food supplement rules apply |
| United States | Permitted as a dietary ingredient | Normal dietary supplement rules apply |
Rules move quickly here. Treat this table as a starting point and confirm with the national authority or your regulatory adviser for each market before you launch or reorder.
What is the EU Article 8 procedure?
Article 8 of Regulation (EC) No 1925/2006 lets the European Commission act when a substance other than a vitamin or mineral, used in foods, may pose a risk. After an assessment by the European Food Safety Authority (EFSA), the substance can be prohibited, restricted, or put under further scrutiny across the EU. For ashwagandha, national food safety heads recommended starting this process in 2024. Until the Commission starts it and EFSA reports, national rules decide.
How brands are adapting
- Sell where it's clearly allowed, and pause or reformulate for markets that ban or tightly restrict it.
- Use root material only, with a defined withanolide level by HPLC, which is what most national limits refer to.
- Keep daily doses conservative and within any national maximum.
- Add clear warnings, for example not for pregnant or breastfeeding women or children, and advice for people with liver or thyroid conditions, as your market requires.
- Keep a safety file: specification, COAs, and the literature behind your dose.
- Watch your claims. Health claims for botanicals are tightly controlled in the EU; see EU health claims for botanicals.
What to specify when buying ashwagandha for Europe
- Botanical name and part: Withania somnifera (L.) Dunal, root
- Withanolide content and test method, HPLC preferred (UV gives higher, non-comparable numbers)
- Extraction solvent, usually water or water-ethanol, with residual solvent results
- Heavy metals, pesticides, ethylene oxide and microbiology to EU limits
Our guides on importing herbal extracts into the EU and ashwagandha powder and capsules go into more detail.
Ashwagandha isn't banned across Europe, but "it's legal in the EU" is no longer a safe assumption. Check each country, every time.
Ashwagandha from Arizone
Arizone International LLP supplies ashwagandha root extract, ashwagandha powder and capsules to export customers, with a certificate of analysis for each batch. We supply to your specification; whether a product can be sold in a given country is for the importer and brand to confirm. Tell us your market and we'll make sure the specification and tests match what you need.
Sources: McGill Office for Science and Society: why did Denmark ban ashwagandha?; Food Safety Magazine: Netherlands set to ban ashwagandha; Regulation (EC) No 1925/2006.
Ashwagandha in Europe Questions
Not EU-wide. Denmark has banned it in food supplements and some other countries restrict it, but there is no EU-wide ban as of October 2026.
Its food authority relied on a 2020 risk assessment by the Technical University of Denmark, which concluded that a safe intake level for the root or extracts couldn't be established.
Yes. It is sold as a food supplement in the UK and as a dietary ingredient in the USA, under each country's normal rules.
It's possible. National authorities recommended an EU review under Article 8 of Regulation 1925/2006 in 2024. If started, EFSA would assess it and the Commission could prohibit or restrict it EU-wide.
